New Study Reveals Deadly Link Between High-Deductible Health Plans and Cancer Survival Rates
The Affordable Care Act's tax credits have largely disappeared, leaving millions of Americans to navigate the complex world of high-deductible health plans. A new study published in the JAMA Network Open has shed light on the devastating consequences of these plans, particularly for cancer patients.
Researchers from Mayo Clinic found that individuals with high-deductible health plans (HDHPs) had significantly worse overall survival rates and lower cancer-specific survival rates compared to those with standard deductible plans. The study, which analyzed data from over 147,000 people, including nearly 9,800 diagnosed with cancer, revealed that HDHPs led to a 46% higher risk of death and a 34% higher risk of death specifically due to cancer.
The findings are particularly alarming for cancer patients, who often require more extensive and costly treatments. The researchers noted that the plans' high out-of-pocket costs can lead people to delay or avoid essential medical care, resulting in poorer health outcomes.
In contrast, individuals without a cancer diagnosis on HDHPs did not exhibit lower survival rates compared to those with other plans, suggesting that these plans may be less detrimental for healthy individuals. However, this does not alleviate concerns about the broader impact of HDHP proliferation, which could exacerbate adverse cancer outcomes in the current political environment.
The study's lead author, Justin Barnes, cautioned that high-deductible health plans can have a disproportionate effect on vulnerable populations, including those with serious medical conditions like cancer. He emphasized the need for patients, policymakers, and the public to be educated about the potential risks associated with HDHPs and to prioritize access to essential care.
As healthcare costs continue to rise, it is crucial that Americans understand the consequences of choosing high-deductible health plans and take steps to protect their well-being and that of loved ones.
The Affordable Care Act's tax credits have largely disappeared, leaving millions of Americans to navigate the complex world of high-deductible health plans. A new study published in the JAMA Network Open has shed light on the devastating consequences of these plans, particularly for cancer patients.
Researchers from Mayo Clinic found that individuals with high-deductible health plans (HDHPs) had significantly worse overall survival rates and lower cancer-specific survival rates compared to those with standard deductible plans. The study, which analyzed data from over 147,000 people, including nearly 9,800 diagnosed with cancer, revealed that HDHPs led to a 46% higher risk of death and a 34% higher risk of death specifically due to cancer.
The findings are particularly alarming for cancer patients, who often require more extensive and costly treatments. The researchers noted that the plans' high out-of-pocket costs can lead people to delay or avoid essential medical care, resulting in poorer health outcomes.
In contrast, individuals without a cancer diagnosis on HDHPs did not exhibit lower survival rates compared to those with other plans, suggesting that these plans may be less detrimental for healthy individuals. However, this does not alleviate concerns about the broader impact of HDHP proliferation, which could exacerbate adverse cancer outcomes in the current political environment.
The study's lead author, Justin Barnes, cautioned that high-deductible health plans can have a disproportionate effect on vulnerable populations, including those with serious medical conditions like cancer. He emphasized the need for patients, policymakers, and the public to be educated about the potential risks associated with HDHPs and to prioritize access to essential care.
As healthcare costs continue to rise, it is crucial that Americans understand the consequences of choosing high-deductible health plans and take steps to protect their well-being and that of loved ones.